Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Clin Cancer Res. 2009 Sep 29;15(19):6208–6216. doi: 10.1158/1078-0432.CCR-09-0592

Table 1.

Descriptive analysis for colorectal cancer cases overall and based on ODC1 genotype

All CRC Cases
n = 400
ODC1 GG
n = 208
ODC1 GA/AA
n = 192
P-value

Median Age (with age range) 56.6 (29-89) 56.8 (29-89) 56.4 (29-82) 0.24

Gender Male 230 (58%) 117 (56%) 113 (59%) 0.60
Female 170 (41%) 91 (44%) 79 (41%)

Ethnicity Non-Hispanic Caucasian 351 (88%) 188 (90%) 163 (85%) 0.14
African American 4 (1%) 2 (1%) 2 (1%)
Caucasian-Hispanic 20 (5%) 11 (5%) 9 (5%)
Asian 23 (6%) 7 (3%) 16 (8%)
Other 2 (<1%) 0 (0%) 2(1%)

Family History of CRC Yes 106 (26%) 56 (27%) 50 (26%) 0.84
No 294 (74%) 152 (73%) 142 (74%)

Stage at Diagnosis I 146 (37%) 72 (35%) 74 (39%) 0.49
II 128 (32%) 72 (35%) 56 (29%)
III 126 (31%) 64 (31%) 62 (32%)

Colon/Rectum Site Proximal and transverse 120 (30%) 65 (31%) 55 (29%) 0.90
Descending 22 (6%) 12 (6%) 10 (5%)
Sigmoid 110 (28%) 55(26%) 55 (29%)
Rectosigmoid 57 (14%) 32 (15%) 25 (13%)
Mid-Low Rectum 86 (22%) 41 (20%) 45 (23%)
Colorectum, unspecified 5 (1%) 3 (1%) 2 (1%)

Histologic Subtype Adenocarcinoma Mucinous 364 (91%) 183 (88%) 181 (94%) 0.16
adenocarcinoma 26 (7%) 18 (9%) 8 (4%)
Carcinoma 9 (2%) 6 (3%) 3 (2%)
NOS 1 (<1%) 1 (<1%) 0 (0%)

Tumor Grade I 62 (17%) 27 (14%) 35 (20%) 0.36
II 261 (71%) 140 (73%) 121 (68%)
III 46 (13%) 24 (13%) 22 (12%)
No. missing 31 17 14

Surgical Treatment Yes 395 (99%) 204 (98%) 191 (99%) 0.21
No 5 (1%) 4 (2%) 1 (1%)

Radiation Therapy Yes 63 (16%) 29 (14%) 34 (18%) 0.30
No 337 (84%) 179 (86%) 158 (82%)

Chemotherapy Yes 170 (45%) 84 (44%) 86 (46%) 0.56
No 208 (55%) 109 (56%) 99 (54%)
No. missing 22 15 7